Michael Fahey

Projects

Projects per year 2007 2018 2019 2022 2023 2028

• 16 Active
• 26 Finished

Projects per year

Search results

• Active

  A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy.

  Fahey, M. (Primary Chief Investigator (PCI))

  30/08/23 → 29/08/28

  Project: Research

• Investigating the effects of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) on gene regulation and immune dysfunction in paediatric acute-onset neuropsychiatric syndrome: An open-label study

  Fahey, M. (Primary Chief Investigator (PCI))

  25/07/23 → 24/07/28

  Project: Research

• A Phase 2, multicenter, open-label, long-term safety study of LP352 in subjects with developmental and epileptic encephalopathy who completed Study LP352-201 and are candidates for continuous treatment for up to 52 weeks

  Fahey, M. (Primary Chief Investigator (PCI))

  25/07/23 → 24/07/28

  Project: Research

• MitoHOPE: Introducing Mitochondrial Donation in AustraliaL The MitoHOPE (Healthy Outcomes Pilot and Evaluation) Program

  Carroll, J. (Primary Chief Investigator (PCI)), Herbert, M. (Chief Investigator (CI)), Christodoulou, J. (Chief Investigator (CI)), Thorburn, D. R. (Chief Investigator (CI)), Mills, C. (Chief Investigator (CI)), Zander-Fox, D. L. (Chief Investigator (CI)), Robker, R. (Chief Investigator (CI)), Rombauts, L. (Chief Investigator (CI)), Sallevelt, S. (Chief Investigator (CI)), Ludlow, K. (Chief Investigator (CI)), Coman, D. J. (Chief Investigator (CI)), Ellaway, C. J. (Chief Investigator (CI)), Mackey, D. A. (Chief Investigator (CI)), Delatycki, M. B. (Chief Investigator (CI)), Yau, W. Y. (Chief Investigator (CI)), Tchan, M. C. (Chief Investigator (CI)), Long, J. C. (Chief Investigator (CI)), Hardy, T. (Chief Investigator (CI)), Adhikari, D. (Chief Investigator (CI)), Choudhary, M. (Chief Investigator (CI)), Hyslop, L. A. (Chief Investigator (CI)), Mann, J. (Chief Investigator (CI)), Ryan, M. (Chief Investigator (CI)), Hodges, R. (Chief Investigator (CI)), Hui, L. (Chief Investigator (CI)), Kamien, B. A. (Chief Investigator (CI)), Mallett, A. J. (Chief Investigator (CI)), Semsarian, C. (Chief Investigator (CI)), Wallis, M. J. (Chief Investigator (CI)), Wall, M. (Chief Investigator (CI)), Zoungas, S. (Chief Investigator (CI)), Goranitis, I. (Chief Investigator (CI)), Gyngell, C. (Chief Investigator (CI)), Hammarberg, K. (Chief Investigator (CI)), Sparrow, R. (Chief Investigator (CI)), Warren, N. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Stutterd, C. A. (Associate Investigator (AI)), Schweitzer, D. (Associate Investigator (AI)), McGillivray, G. (Associate Investigator (AI)), Savulescu, J. (Associate Investigator (AI)), Panetta, J. (Associate Investigator (AI)), Kava, M. P. (Associate Investigator (AI)), Freckmann, M.-L. (Associate Investigator (AI)), Lynch, M. (Associate Investigator (AI)), Lamont, P. J. (Associate Investigator (AI)), Scott, R. (Associate Investigator (AI)), Ware, T. (Associate Investigator (AI)), Mowat, D. (Associate Investigator (AI)), Jones, K. J. (Associate Investigator (AI)), Green, S. (Associate Investigator (AI)), Wolfe, R. (Associate Investigator (AI)), Hackett, A. (Associate Investigator (AI)), Bratkovic, D. (Associate Investigator (AI)), Horton, A. (Associate Investigator (AI)) & Blok, R. (Project Manager)

  Monash University – Internal Faculty Contribution, Australian Genomics, Centenary Institute of Cancer Medicine & Cell Biology, James Cook University, Lyons Eye Institute Limited, Macquarie University, Murdoch Children's Research Institute, Australian Mitochondrial Disease Foundation Limited (trading as Mito Foundation), Monash IVF Group Limited, Perron Institute for Neurological and Translational Science Limited, Queensland Children's Hosptial , Tasmanian Clinical Genetics Service, University of Adelaide, Victorian Assisted Reproductive Treatment Authority (VARTA) (Victoria), Women's and Children's Health Care Network Incorporated, Western Sydney Local Health District (WSLHD)

  1/06/23 → 31/05/28

  Project: Research

• A Phase 1b/2a randomized, double-blind, placebo-controlled, parallel-group, dose-escalation study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of LP352 in subjects with developmental and epileptic encephalopathies

  Fahey, M. (Primary Chief Investigator (PCI))

  29/03/23 → 28/03/28

  Project: Research

• Synergising Biomarkers - Fetal Growth Restriction (FGR) Project

  Fahey, M. (Primary Chief Investigator (PCI)), Palmer, K. (Chief Investigator (CI)), Camm, E. (Chief Investigator (CI)), Lobb, R. J. (Chief Investigator (CI)), Bradford, D. K. (Chief Investigator (CI)) & Ross, J. (Chief Investigator (CI))

  1/02/23 → 30/06/25

  Project: Research

• A Phase I/II Double-Blind, Randomised and Controlled-to-Open-Label Study Assessing the Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in Young People with Autism Spectrum Disorder

  Fahey, M. (Primary Chief Investigator (PCI))

  3/01/23 → 2/01/28

  Project: Research

• The Monash Partners Children’s Acute Care Data Project: Optimising the use of electronic medical records data to improve hospital care for children

  Craig, S. (Primary Chief Investigator (PCI)), Williams, K. (Chief Investigator (CI)), Lovett, A. (Chief Investigator (CI)), Taylor, D. A. (Chief Investigator (CI)), Nixon, G. (Chief Investigator (CI)), Coleman, J. M. (Chief Investigator (CI)), Winderlich, J. (Chief Investigator (CI)), Noorman, J. (Chief Investigator (CI)), Parkhurst, K. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Nataraja, R. (Chief Investigator (CI)), Hunt, R. (Chief Investigator (CI)), Lamont, S. (Chief Investigator (CI)), Nold, M. (Chief Investigator (CI)), Polglase, G. (Chief Investigator (CI)), Jones, A. (Chief Investigator (CI)) & Pigott, C. (Chief Investigator (CI))

  1/01/23 → …

  Project: Research

• TRANSMIT: TRANSMIT: A multifaceted knowledge TRANslation Strategy iMprovIng funcTion in children and youth with cerebral palsy

  Novak, I. (Primary Chief Investigator (PCI)), Badawi, N. (Chief Investigator (CI)), Morgan, C. (Chief Investigator (CI)), Sakzewski, L. (Chief Investigator (CI)), Boyd, R. N. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Burns, J. (Chief Investigator (CI)), Jackman, M. L. (Chief Investigator (CI)), Bradford, D. K. (Chief Investigator (CI)) & Namara, M. M. (Chief Investigator (CI))

  1/09/22 → 31/08/27

  Project: Research

• A national functional diagnostic program for therapy development in congenital muscle disease

  Currie, P. (Primary Chief Investigator (PCI)), McLean, C. (Chief Investigator (CI)), Mitchell, C. (Chief Investigator (CI)), Lynch, G. S. (Chief Investigator (CI)), Houweling, P. J. (Chief Investigator (CI)), Mcgrath, M. (Chief Investigator (CI)), Ruparelia, A. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Yiu, E. M. (Chief Investigator (CI)), Cairns, A. (Chief Investigator (CI)), Forbes, R. (Chief Investigator (CI)), Farrar, M. (Chief Investigator (CI)), Porrello, E. R. (Chief Investigator (CI)) & Gregorevic, P. (Chief Investigator (CI))

  1/07/22 → 30/06/27

  Project: Research

• Childhood febrile convulsions - do treatment patterns determine the risk of early recurrence?

  Craig, S. (Primary Chief Investigator (PCI)), Dalziel, S. R. (Chief Investigator (CI)), Borland, M. L. (Chief Investigator (CI)), Babl, F. E. (Chief Investigator (CI)), Kasza, J. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Furyk, J. S. (Chief Investigator (CI)), Tavender, E. J. (Chief Investigator (CI)), Phillips, N. A. (Chief Investigator (CI)), George, S. (Chief Investigator (CI)), Callander, E. (Associate Investigator (AI)), Nelson, L. (Associate Investigator (AI)), Kochar, A. (Associate Investigator (AI)) & Haskell, L. (Associate Investigator (AI))

  National Health and Medical Research Council (NHMRC) (Australia)

  1/07/22 → 30/06/27

  Project: Research

• Early, novel and accessible intervention for children with developmental regression

  Williams, K. (Primary Chief Investigator (PCI)), Olivier, P. (Chief Investigator (CI)), Bourke-Taylor, H. (Chief Investigator (CI)), Yap, M. (Chief Investigator (CI)), Brignell, A. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Hunter, M. (Chief Investigator (CI)), Sim, W. (Chief Investigator (CI)), Ure, A. (Chief Investigator (CI)), Xie, J. (Chief Investigator (CI)), Furley, K. (Chief Investigator (CI)), Elvidge, K. (Associate Investigator (AI)) & Wake, M. (Associate Investigator (AI))

  1/07/22 → 1/07/27

  Project: Research

• Cerebral Palsy SYNERGY Network to Protect, Repair and improve Outcomes

  Boyd, R. N. (Primary Chief Investigator (PCI)), Novak, I. (Chief Investigator (CI)), Rose, S. E. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Colditz, P. B. (Chief Investigator (CI)), Hunt, R. (Chief Investigator (CI)), Badawi, N. (Chief Investigator (CI)), Fripp, J. (Chief Investigator (CI)), Sakzewski, L. (Chief Investigator (CI)), Corbett, M. A. (Chief Investigator (CI)), McIntyre, S. (Associate Investigator (AI)), Ware, R. S. (Associate Investigator (AI)), Miller, S. (Associate Investigator (AI)), Gécz, J. (Associate Investigator (AI)), Locke, W. (Associate Investigator (AI)), Palmer, K. (Associate Investigator (AI)), Morgan, C. (Associate Investigator (AI)), Pannek, K. (Associate Investigator (AI)), Comans, T. A. (Associate Investigator (AI)) & Malhotra, A. (Associate Investigator (AI))

  1/01/22 → 31/12/26

  Project: Research

• A Phase I/II Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (FEN164) in Children with Autism Spectrum Disorder.

  Fahey, M. (Primary Chief Investigator (PCI))

  27/10/21 → 26/11/26

  Project: Research

• School Readiness child outcomes of early neuroprotection/ early neurorehabilitation for infants at high risk of Cerebral Palsy- in the first 2,000 days

  Boyd, R. N. (Primary Chief Investigator (PCI)), Novak, I. (Chief Investigator (CI)), Morgan, C. (Chief Investigator (CI)), Sakzewski, L. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Ware, R. S. (Chief Investigator (CI)), Comans, T. A. (Chief Investigator (CI)), Whittingham, K. (Chief Investigator (CI)), Trost, S. G. (Chief Investigator (CI)), Pannek, K. (Chief Investigator (CI)), Palmer, K. (Associate Investigator (AI)) & Morgan, C. (Chief Investigator (CI))

  1/06/21 → 31/05/25

  Project: Research

• PROTECT Me: Assessing Antenatal Maternal Melatonin Supplementation in Fetal Growth Restriction to Improve Neurodevelopmental Outcomes

  Palmer, K. (Primary Chief Investigator (PCI)), Wallace, E. (Chief Investigator (CI)), Groom, K. (Chief Investigator (CI)), Mol, B. (Chief Investigator (CI)), Davies, M. (Chief Investigator (CI)), Fahey, M. (Chief Investigator (CI)), Anderson, P. (Chief Investigator (CI)), Goergen, S. (Chief Investigator (CI)), Pannek, K. (Chief Investigator (CI)) & Miller, S. (Chief Investigator (CI))

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/20 → 31/12/25

  Project: Research